Structure Therapeutics, Inc. (NASDAQ:GPCR) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Eric Dobmeier Other companies: Jade Biosciences, Inc. (Director · Since at least Apr 28, 2025); Janux Therapeutics, Inc. (Director · Since at least Jul 19, 2024); Aduro Biotech Inc (President, CEO, Director · Oct 5, 2020 – Aug 11, 2023 · Past); Atara Biotherapeutics, Inc. (Director · Jun 27, 2019 – Nov 10, 2023 · Past); Adaptive Biotechnologies Corporation (Director · Jun 26, 2019 – Feb 14, 2021 · Past) | Director · Since at least Feb 2, 2023 |
| Matthew Lang Other companies: Metsera, Inc. (CHIEF LEGAL OFFICER · Since at least Apr 28, 2025); Lyell Immunopharma, Inc. (Chief Business Officer · Jul 1, 2023 – Feb 10, 2025 · Past); Myovant Sciences Ltd (General Counsel & Corp. Secy. · Apr 5, 2019 – Mar 10, 2023 · Past) | COO & GC · Since at least Apr 15, 2026 |
| Ashley Hall Other companies: OnKure Therapeutics, Inc. (Chief Development Officer · Oct 11, 2020 – Aug 28, 2023 · Past); Esperion Therapeutics, Inc. (Chief Development Officer · Feb 26, 2020 – Jan 28, 2021 · Past) | Chief Development Officer · Since at least Sep 18, 2024 |
| Joanne Waldstreicher Other companies: Becton, Dickinson and Company (Director · Since at least Jul 24, 2023) | Director · Since at least Feb 2, 2023 |
| Melita Sun Jung Other companies: Terns Pharmaceuticals, Inc. (Chief Business Officer · Apr 22, 2024 – Jan 30, 2025 · Past) | Chief Business Officer · Feb 2, 2023 – Feb 7, 2023 · Past |
| Raymond C Stevens Other companies: Danaher Corporation (Director · Since at least Feb 21, 2017) | CHIEF EXECUTIVE OFFICER, Director · Since at least Feb 2, 2023 |
| John Joseph Berrios | Chief Commercial Officer · Since at least Aug 6, 2026 |
| Jun Yoon | Chief Financial Officer · Since at least Nov 5, 2026 |
| Xichen Lin | CHIEF SCIENTIFIC OFFICER · Since at least Feb 2, 2023 |